http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#head http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://www.nanopub.org/nschema#hasAssertion http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#assertion http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://www.nanopub.org/nschema#hasProvenance http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#provenance http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://www.nanopub.org/nschema#hasPublicationInfo http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#publicationInfo http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#assertion http://bio2rdf.org/drugbank:DB00243 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00243_DB00257 http://bio2rdf.org/drugbank:DB00257 http://bio2rdf.org/drugbank_vocabulary:ddi-interactor-in http://bio2rdf.org/drugbank_resource:DB00243_DB00257 http://bio2rdf.org/drugbank_resource:DB00243_DB00257 http://purl.org/dc/terms/identifier drugbank_resource:DB00243_DB00257 http://bio2rdf.org/drugbank_resource:DB00243_DB00257 http://purl.org/dc/terms/title DDI between Ranolazine and Clotrimazole - CYP3A4 Inhibitors (Moderate) such as clotrimazole may increase the serum concentration of ranolazine. Limit the ranolazine dose to a maximum of 500mg twice daily in patients concurrently receiving moderate CYP3A4 inhibitors (e.g., diltiazem, verapamil, erythromycin, etc.). Monitor for increased effects/toxicity of ranolazine during concomitant use. http://bio2rdf.org/drugbank_resource:DB00243_DB00257 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://bio2rdf.org/drugbank_vocabulary:Drug-Drug-Interaction http://bio2rdf.org/drugbank_resource:DB00243_DB00257 http://www.w3.org/2000/01/rdf-schema#label DDI between Ranolazine and Clotrimazole - CYP3A4 Inhibitors (Moderate) such as clotrimazole may increase the serum concentration of ranolazine. Limit the ranolazine dose to a maximum of 500mg twice daily in patients concurrently receiving moderate CYP3A4 inhibitors (e.g., diltiazem, verapamil, erythromycin, etc.). Monitor for increased effects/toxicity of ranolazine during concomitant use. [drugbank_resource:DB00243_DB00257] http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#provenance http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#assertion http://semanticscience.org/resource/SIO_000253 http://bio2rdf.org/drugbank_resource:bio2rdf.dataset.drugbank.R3 http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#publicationInfo http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#signature.MC4CFQCUV03roKud http://purl.org/nanopub/x/hasPublicKey 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 http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#signature.MC4CFQCUV03roKud http://purl.org/nanopub/x/hasSignature MC4CFQCUV03roKud7zgtNoi8djrYNGXU2AIVAIr+4Pv/t2KPe9ypVMjzmwRM/+4g http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#signature.MC4CFQCUV03roKud http://purl.org/nanopub/x/signedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://purl.org/dc/terms/created 2018-03-30T11:12:32.726+02:00 http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://purl.org/dc/terms/license https://creativecommons.org/licenses/by-nc/4.0/ http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://purl.org/nanopub/x/hasSignatureElement http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw#signature.MC4CFQCUV03roKud http://bio2rdf.org/drugbank_resource:DB00243_DB00257_nanopub.RAmMyYwucOkmQ16Eov2BMFrfjdkik4Suy3oFdFLkw6Irw http://www.w3.org/ns/prov#wasGeneratedBy https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#specializationOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://purl.org/dc/terms/identifier 3c184e6c-ceb8-4275-a679-71dfbdac2a11 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#used https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasAssociatedWith https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB https://github.com/tkuhn/bio2rdf2nanopub#instance.MIIBtzCCASwGByqGSM44BAEwggEfAoGB.3c184e6c-ceb8-4275-a679-71dfbdac2a11 http://www.w3.org/ns/prov#wasStartedBy http://orcid.org/0000-0002-1267-0234 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/dc/terms/isVersionOf https://github.com/tkuhn/bio2rdf2nanopub https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://purl.org/pav/version eda7951a5f6c622c5d2132f50c3093138484a349 https://github.com/tkuhn/bio2rdf2nanopub/tree/eda7951a5f6c622c5d2132f50c3093138484a349 http://www.w3.org/ns/prov#wasAttributedTo http://orcid.org/0000-0002-1267-0234